Endotoxin/TLR3 signal transduction pathway: role in lung injury

 
crossMark

doi: 10.18081/2333-5106/015-06/333-344
American Journal of BioMedicine Volume 3, Issue 6, pages 333-344
Published: June 25, 2015


Mariana B. Friedman, Halley A. Schmid, Astor S. Josef, Mark Longton

Abstract

Toll-like receptor 3 (TLR3) recognize extracellular RNA (exRNA) released from lung diseases of immune origin but the pathogenesis remain little described in endotoxin lung injury. We investigated the expression and function of TLR3 in peripheral blood mononuclear cells (PBMC) of endotoxin lung injury. TLR3(-/-) and wild-type (WT) mice were exposed to to 1 hr of left lung warm ischemia followed by 6 hr of reperfusion. We found that TLR3(-/-) mice had significantly reduced AKT phosphorylation and markedly decreased the expression of proinflammatory chemokine/cytokine levels and neutrophil recruitment in the left lung following ischemia-reperfusion as compared with wildtype mice. These results indicate that endotoxin functions as a differential regulator of TLR3 signaling pathways by facilitating TLR3 endocytic trafficking in monocytes in the lung inflammatory response to endotoxin.

Keywords: TLR3; AKT phosphorylation; proinflammatory cytokine; Lung injury


Limited Access              Full Text-PDF                   Cited-by-Linkin


References

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. [PubMed]

2. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll‐like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279:7370-7377. [PubMed]

3. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for toll‐like receptor 3. J Biol Chem 2004; 279:12542-12550. [PubMed]

4. Cavassani KA, Ishii M, Wen H, et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med. 2008; 205:2609-2621. [PubMed]

5. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double‐stranded RNA and activation of NF‐kappaB by toll‐like receptor 3. Nature 2001; 413:732-738.  [PubMed]

6. Pinsky, MR. Dysregulation of the immune response in severe sepsis. Am. J. Med Sci 2004;328:220–229. [PubMed]

7. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol 2006; 6:823–835. [PubMed]

8. Doughty LA, Carlton S, Galen B, Cooma-Ramberan I, Chung CS, Ayala A. Activation of common antiviral pathways can potentiate inflammatory responses to septic shock. Shock 2006; 26:187–194. [PubMed]

9. MacDonald KL, Osterholm MT, Hedberg CW, et al. Toxic shock syndrome: a newly recognized complication of influenza and influenza-like illness. JAMA 1987; 257:1053–1058. [PubMed]

10. Zhang WJ, Sarawar S, Nguyen P, et al. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J Immunol 1996;157:5049– 5060.

11. Fejer G, Szalay K, Gyory I, et al. Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock. J Immunol 2005;175:1498 – 1506. [PubMed]

12.  Fink MP. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186 – 196. [PubMed]

13. Latifi SQ, O’Riordan MA, Levine AD. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 2002;70:4441 – 4446. [PubMed]

14. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003;301:640 – 643. [PubMed]

15. Biron CA. Interferons α and β as immune regulators—a new look. Immunity 2001;14:661 – 664. [PubMed]

16. Jiang Z, Mak TW, Sen G, Li X. Toll-like receptor 3-mediated activation of NFκB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc Natl Acad Sci USA 2004;101:3533 – 3538. [PubMed]

17. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKα and TBK I are essential components of the IRF3 signaling pathway. Nature 2003;4:491 – 496. [PubMed]

18. WA Everett, NG Yousif, L Ao, JC Cleveland, X Fullerton David A, Meng. Ghrelin reduces myocardial injury following global ischemia and reperfusion via suppression of myocardial inflammatory response. American Journal of BioMedicine 2013;1(1):38-48. [Abstract/Full-Text]

19. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003;300:1148 – 1151. [PubMed]

20. Borchers MT, Wesselkamper SC, Curull V, et al. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest 2009;119: 636-649. [PubMed]

21. Orr MT, Lanier LL. Natural killer cell education and tolerance. Cell 2010; 142:847-856. [PubMed]

22. Yousif NG, Ao L, Fullerton DA, Meng X. Myocardial tissue TLR4-mediated mcp-1 production contributes to the mechanisms of myocardial injury following cold ischemia and reperfusion. Shock 2011; 35, 65-65.

 

 

Print Friendly, PDF & Email